Found: 119
Select item for more details and to access through your institution.
Stage 4N neuroblastoma before and during the era of anti‐G<sub>D2</sub> immunotherapy.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 12, p. 2019, doi. 10.1002/ijc.34693
- By:
- Publication type:
- Article
Promise and Challenges of T Cell Immunotherapy for Osteosarcoma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12520, doi. 10.3390/ijms241512520
- By:
- Publication type:
- Article
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.
- Published in:
- Theranostics, 2023, v. 13, n. 15, p. 5469, doi. 10.7150/thno.87489
- By:
- Publication type:
- Article
Genomic Breakpoint Characterization and Transcriptome Analysis of Metastatic, Recurrent Desmoplastic Small Round Cell Tumor.
- Published in:
- Sarcoma, 2023, p. 1, doi. 10.1155/2023/6686702
- By:
- Publication type:
- Article
Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1104693
- By:
- Publication type:
- Article
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 2, p. 1, doi. 10.1002/pbc.30075
- By:
- Publication type:
- Article
Immunotherapy with anti‐G<sub>D2</sub> monoclonal antibody in infants with high‐risk neuroblastoma.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 2, p. 259, doi. 10.1002/ijc.34233
- By:
- Publication type:
- Article
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1106597
- By:
- Publication type:
- Article
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01383-4
- By:
- Publication type:
- Article
Pretargeting: A Path Forward for Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1302, doi. 10.2967/jnumed.121.262186
- By:
- Publication type:
- Article
Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01337-w
- By:
- Publication type:
- Article
Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 423, doi. 10.3390/ijms23010423
- By:
- Publication type:
- Article
KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 1, p. 1, doi. 10.1002/pbc.29344
- By:
- Publication type:
- Article
Phase I Trial of Oral Yeast-Derived β-Glucan to Enhance Anti-GD2 Immunotherapy of Resistant High-Risk Neuroblastoma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6265, doi. 10.3390/cancers13246265
- By:
- Publication type:
- Article
Influence of Fc modifications and IgG subclass on biodistribution of humanized antibodies targeting L1CAM.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262383
- By:
- Publication type:
- Article
Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02821-8
- By:
- Publication type:
- Article
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.772862
- By:
- Publication type:
- Article
Influence of Fc modifications and IgG subclass on biodistribution of humanized antibodies targeting L1CAM.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262383
- By:
- Publication type:
- Article
Influence of Fc modifications and IgG subclass on biodistribution of humanized antibodies targeting L1CAM.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262383
- By:
- Publication type:
- Article
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01156-5
- By:
- Publication type:
- Article
Potent antitumor effect of T cells armed with anti-GD2 bispecific antibody.
- Published in:
- 2021
- By:
- Publication type:
- journal article
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab—pharmacokinetic modeling to optimize therapeutic index.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1166, doi. 10.1007/s00259-020-05050-z
- By:
- Publication type:
- Article
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-01012-y
- By:
- Publication type:
- Article
Editorial: Bispecific Antibodies for T-Cell Based Immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Reduced‐dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 9, p. 1, doi. 10.1002/pbc.28364
- By:
- Publication type:
- Article
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 534, p. 1, doi. 10.1126/scitranslmed.aax1315
- By:
- Publication type:
- Article
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.219576
- By:
- Publication type:
- Article
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00537
- By:
- Publication type:
- Article
Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 1, p. 101, doi. 10.1007/s11060-019-03139-6
- By:
- Publication type:
- Article
Treatment and outcome of adult‐onset neuroblastoma.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 5, p. 1249, doi. 10.1002/ijc.31399
- By:
- Publication type:
- Article
Dose-escalation is needed for gross disease in high-risk neuroblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 11, p. 1735, doi. 10.2967/jnumed.117.193250
- By:
- Publication type:
- Article
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178593
- By:
- Publication type:
- Article
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 2, p. 480, doi. 10.1002/ijc.30440
- By:
- Publication type:
- Article
Temporal stability and molecular persistence of the bone marrow plasma cell antibody repertoire.
- Published in:
- Nature Communications, 2016, v. 7, n. 12, p. 13838, doi. 10.1038/ncomms13838
- By:
- Publication type:
- Article
Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Arsenic Trioxide as a Radiation Sensitizer for <sup>131</sup>I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 231, doi. 10.2967/jnumed.115.161752
- By:
- Publication type:
- Article
A dual-specific anti- IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 9, p. 2243, doi. 10.1002/ijc.29588
- By:
- Publication type:
- Article
Immunotherapy of childhood Sarcomas.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00181
- By:
- Publication type:
- Article
Radioimmunotherapy of human tumours.
- Published in:
- Nature Reviews Cancer, 2015, v. 15, n. 8, p. 509, doi. 10.1038/nrc3987
- By:
- Publication type:
- Article
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 8, p. 1326, doi. 10.1002/pbc.25513
- By:
- Publication type:
- Article
Osteochondroma in long-term survivors of high-risk neuroblastoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 12, p. 2090, doi. 10.1002/cncr.29316
- By:
- Publication type:
- Article
Radioimmunotherapy of human tumours.
- Published in:
- Nature Reviews Cancer, 2015, v. 15, n. 6, p. 347, doi. 10.1038/nrc3925
- By:
- Publication type:
- Article
Radioimmunotherapy of human tumours.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Antibody induced pain in children: An opportunity to study pain mechanism, IgG design and analgesics.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 2, p. 476, doi. 10.1002/ijc.29007
- By:
- Publication type:
- Article
Key role for myeloid cells: Phase II results of anti-G<sub>D2</sub> antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 9, p. 2199, doi. 10.1002/ijc.28851
- By:
- Publication type:
- Article